Hildred Capital Partners

David Solomon and Andrew Goldman serve as co-founders and managing partners and lead the firm's investment decisions. Both are involved in originating, evaluating, and managing platform investments. The concentrated partnership structure means major strategic and allocation decisions remain with the co-founders.

Hildred targets healthcare services companies including behavioral health, dental services, home-based care, and technology-enabled healthcare providers. The firm looks for fragmented markets where operational improvements and consolidation can create value, typically in subsectors that are reimbursement-dependent and regulated.

Yes. Hildred is a sector-focused private equity firm that invests exclusively in middle-market healthcare companies. The firm does not pursue deals outside healthcare services and adjacent digital health opportunities, making it a dedicated, not opportunistic, healthcare investor.

Hildred pursues control buyouts and growth-equity investments in middle-market healthcare companies. Based on its disclosed fund sizes — a roughly $175 million first fund and a roughly $475 million second fund as of 2019 — the firm writes equity checks in the range appropriate for lower- to mid-middle-market platform acquisitions, though specific check sizes remain undisclosed.

Hildred relies on the sector relationships and operational networks of its co-founders and investment team. As a healthcare-dedicated firm, its deal flow comes from proprietary outreach to founder-owned businesses, intermediary relationships focused on healthcare services, and repeat engagements with operators from prior transactions. The firm does not operate a public deal portal.